As part of its mission to foster the highest quality, evidence-based and ethical spine care, NASS continues to develop credible and reasonable coverage recommendations to assist payors, providers, and patients in defining appropriate and fair coverage decisions. NASS evidence-based coverage recommendations are developed to advocate for NASS’ positions on various clinical and practice issues to ensure continued provision of quality spine care.
To develop these first-of-their kind coverage recommendations, NASS’ multi-disciplinary team of spine specialists systematically reviews available scientific literature. Searches are limited to systematic reviews, meta-analyses, clinical guidelines, and most importantly, randomized controlled trials. Using an evidence-based approach when possible, the team works together to develop the recommendations. In the absence of high-level data, NASS coverage recommendations reflect the multi-specialty experience and expertise of the committee members in order to present reasonable standard practice indications in the United States. Click here to access NASS’ Coverage Recommendations Methodology!
NASS Wants to Hear From You!
The NASS Coverage Committee extends its sincere appreciation for the overwhelmingly positive feedback we received on our previously published coverage policy recommendations. These helpful comments and suggestions help us better represent the needs of our members and achieve our mission of promoting ethical and evidence-based spine care.
We would like to keep this valuable exchange of ideas flowing by offering a 30-day public comment period on our latest coverage policy recommendations on Intrathecal Drug Delivery Systems. NASS encourages interested parties to submit any comments to these proposed documents to firstname.lastname@example.org by 2/10/17. At the end of the public comment period, comments will be reviewed and considered by the NASS Coverage Committee. Where appropriate, the Committee will make edits and then publish the final coverage recommendations here.
Proposed Coverage Policy Recommendations
Intrathecal Drug Delivery Systems